<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    CohBar, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About CohBar, Inc.

    CohBar, Inc. is a leader in the research and development of mitochondria based therapeutics (MBTs), an emerging class of drugs with the potential to treat a wide range of diseases associated with aging and metabolic dysfunction including non-alcoholic steatohepatitis (NASH), obesity, Type 2 diabetes (T2D), cancer, cardiovascular disease and CNS disorders. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Steven B. Engle, M.S.
    • FOUNDED
      2007
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Tiziana Life Sciences plc

    Tiziana Life Sciences plc

    Tiziana Life Sciences is a dual-listed (NASDAQ:TLSA, AIM:TILS) clinical stage biot...

    Tiziana Life Sciences is a dual-listed (NASDAQ:...

    Filing Type:    PU
    Medidata Solutions, Inc.

    Medidata Solutions, Inc.

    Powered by artificial intelligence and delivered by the #1 ranked industry experts...

    Powered by artificial intelligence and delivere...

    Filing Type:    PU
    Kamada Ltd.

    Kamada Ltd.

    Kamada Ltd. is focused on plasma-derived protein therapeutics for orphan indicatio...

    Kamada Ltd. is focused on plasma-derived protei...

    Filing Type:    PU
    KalVista Pharmaceuticals, Inc.

    KalVista Pharmaceuticals, Inc.

    KalVista is a pharmaceutical company focused on the discovery, development and com...

    KalVista is a pharmaceutical company focused on...

    Filing Type:    PU
    Neuralstem, Inc.

    Neuralstem, Inc.

    Neuralstem is a biopharmaceutical company developing novel treatments for nervous ...

    Neuralstem is a biopharmaceutical company devel...

    Filing Type:    PU
    Mereo BioPharma Group plc

    Mereo BioPharma Group plc

    Mereo BioPharma is a biopharmaceutical company focused on the development and comm...

    Mereo BioPharma is a biopharmaceutical company ...

    Filing Type:    PU
    NextCure, Inc.

    NextCure, Inc.

    NextCure is a clinical-stage biopharmaceutical company committed to discovering an...

    NextCure is a clinical-stage biopharmaceutical ...

    Filing Type:    PU
    20/20 GeneSystems, Inc.

    20/20 GeneSystems, Inc.

    20/20 GeneSystems, Inc. an early stage digital diagnostics company with the core m...

    20/20 GeneSystems, Inc. an early stage digital ...

    Fundraising Status:    SASBEC
    Filing Type:    RA
    Celyad SA

    Celyad SA

    Celyad is a biopharmaceutical company, specialized in CAR-T cell therapy, that is ...

    Celyad is a biopharmaceutical company, speciali...

    Filing Type:    PU
    Midatech Pharma PLC

    Midatech Pharma PLC

    Midatech is an international specialty pharmaceutical company focused on the devel...

    Midatech is an international specialty pharmace...

    Filing Type:    PU
    MannKind Corporation

    MannKind Corporation

    At MannKind Corporation (NASDAQ: MNKD), we focus on the discovery, development and...

    At MannKind Corporation (NASDAQ: MNKD), we focu...

    Filing Type:    PU
    Valeritas Holdings, Inc.

    Valeritas Holdings, Inc.

    Valeritas is a commercial-stage medical technology company focused on improving he...

    Valeritas is a commercial-stage medical technol...

    Filing Type:    PU
    Mesoblast Limited

    Mesoblast Limited

    Mesoblast Limited (Nasdaq: MESO; ASX:MSB) is a world leader in developing allogene...

    Mesoblast Limited (Nasdaq: MESO; ASX:MSB) is a ...

    Filing Type:    PU
    Liquidia Technologies, Inc.

    Liquidia Technologies, Inc.

    Liquidia is a late-stage clinical biopharmaceutical company focused on the develop...

    Liquidia is a late-stage clinical biopharmaceut...

    Filing Type:    PU
    CHF Solutions, Inc.

    CHF Solutions, Inc.

    CHF Solutions is focused on improving the quality of life for patients suffering f...

    CHF Solutions is focused on improving the quali...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.